3 ms·
Bexarotene, the drug used in this study, is already approved and available for certain types of cancer treatment. The problem is that the side effects are sever
by PragmaticPulp 6y ago
Bexarotene, the drug used in this study, is already approved and available for certain types of cancer treatment. The problem is that the side effects are severe. Severe side effects can be acceptable in relatively short term cancer treatment, but untenable for lifelong treatment in Multiple Sclerosis patients.
Specifically, the thyroid effects of Bexarotene are so common and significant that one study even recommended that patients be given adjunctive thyroid medication when beginning treatment, even when low doses are used: https://pubmed.ncbi.nlm.nih.gov/30903705/ https://pubmed.ncbi.nlm.nih.gov/30903705/
Likewise, the effects on blood lipids are significant enough that patients are frequently forced to take statins during their course of treatment: https://pubmed.ncbi.nlm.nih.gov/29805374/ https://pubmed.ncbi.nlm.nih.gov/29805374/
Assuming an MS patient would have to take this drug for a lifetime, or at least use it frequently, suggests that these side effects could worsen quality of life or even shorten lifespan more than MS itself.
Promising drug candidate, but no one should be rushing out to find a way to get their hands on a Bexarotene prescription just yet.